Cerevel Therapeutics Holdings Cash from Investing (TTM) Analysis

Cerevel Therapeutics Holdings Inc (CERE)

42.07 +0.17 (+0.41%) USD | NASDAQ | Apr 25, 16:00

42.10 +0.03 (+0.07%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	73.72M
September 30, 2023	197.20M
June 30, 2023	-242.05M
March 31, 2023	-239.51M
December 31, 2022	-388.83M
September 30, 2022	-788.33M
June 30, 2022	-401.67M

Date	Value
March 31, 2022	-469.54M
December 31, 2021	-435.66M
September 30, 2021	-16.98M
June 30, 2021	-23.09M
March 31, 2021	-21.00M
December 31, 2020	-18.89M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-788.33M

Minimum

Sep 2022

197.20M

Maximum

Sep 2023

-213.43M

Average

-239.51M

Median

Mar 2023

Cash from Investing (TTM) Benchmarks